Telia Lietuva AB
F:ZWS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telia Lietuva AB
F:ZWS
|
LT |
|
Nova Eye Medical Ltd
ASX:EYE
|
AU |
|
Millennium Pharmacon International Tbk PT
IDX:SDPC
|
ID |
|
V
|
Vatryggingafelag Islands hf
ICEX:VIS
|
IS |
|
C
|
Campbell Soup Co
XHAM:CSC
|
US |
|
X
|
XL Fleet Corp
F:XLF
|
US |
|
H
|
HIL Ltd
NSE:HIL
|
IN |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZWS's stock price target?
Not Available
ZWS doesn't have any price targets made by Wall Street professionals.
What is Telia Lietuva AB's Revenue forecast?
Projected CAGR
-7%
For the last 14 years the
compound annual growth rate for
Telia Lietuva AB's revenue is
6%.
The projected
CAGR
for the next 12 years is
-7%.
What is Telia Lietuva AB's Operating Income forecast?
Projected CAGR
-7%
For the last 14 years the
compound annual growth rate for
Telia Lietuva AB's operating income is
6%.
The projected
CAGR
for the next 12 years is
-7%.
What is Telia Lietuva AB's Net Income forecast?
Projected CAGR
-6%
For the last 14 years the
compound annual growth rate for
Telia Lietuva AB's net income is
5%.
The projected
CAGR
for the next 12 years is
-6%.